期刊文献+

慢性肾脏病病人凝血功能变化与炎症内皮因子及氧化应激关系 被引量:9

ASSOCIATION OF COAGULATION FUNCTION CHANGES WITH INFLAMMATORY ENDOTHELIAL FACTORS AND OXIDATIVE STRESS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
下载PDF
导出
摘要 目的了解慢性肾脏病(CKD)病人凝血功能变化与炎症内皮因子及氧化应激关系。方法选取CKD病人110例,根据病人肾小球滤过率(GFR)分为1~5期,每期22例;根据病人纤维蛋白原(FIB)检测结果分成非高凝组(FIB<4g/L)和高凝组(FIB≥4g/L),同时选取同期健康体检者30例作为对照组。检测各组血清血小板(PLT)、清蛋白(ALB)、血红蛋白(Hb)、总胆固醇(TC)、C反应蛋白(CRP)、三酰甘油(TG)、Ca2+及肌酐(CR)水平;应用全自动血凝分析仪分别检测各组血清凝血酶时间(TT)、FIB、活化部分凝血活酶时间(APTT)及血浆凝血酶原时间(PT),ELISA法检测血清内皮素-1(ET-1)、D二聚体(D-D)水平,硫代巴比妥酸法检测丙二醛(MDA)水平,黄嘌呤氧化酶比色法检测超氧化物歧化酶(SOD)水平。分析CKD病人凝血功能状况及高凝状况相关危险因素。结果 4、5期CDK病人血清FIB水平较对照组及1、2期病人明显升高,血清D-D水平较对照组及1期病人明显升高,TT、PT较对照组明显延长,差异均有统计学意义(F=12.466~14.620,P<0.05)。高凝组病人血清MDA、TC、ET-1、CR、CRP水平及心血管病发生率均明显高于非高凝组,SOD、ALB及Ca2+均明显低于非高凝组,差异均有统计学意义(t=10.189~14.083,χ2=10.694,P<0.05);两组病人平均年龄、吸烟人数、TG、PLT、Hb含量差异无统计学意义(P>0.05)。Logistic回归分析显示,病人血清CRP与CR水平为出现高凝状况独立危险因素(P<0.05)。结论 CRP与血CR为引发CKD病人高凝状况独立危险因素,病人高凝状况和体内氧化应激、炎症状况有紧密联系。 Objective To investigate the association of coagulation function changes with inflammatory endothelial factors and oxidative stress in patients with chronic kidney disease(CKD).Methods A total of 110patients with CKD were enrolled,and according to glomerular filtration rate,they were divided into stages 1-5,with 22patients in each stage;according to fibrinogen(FIB),they were divided into non-hypercoagulation group(FIB<4g/L)and hypercoagulation group(FIB≥4g/L).A total of 30individuals who underwent physical examination were enrolled as control group.The serum levels of platelet(PLT),albumin(Alb),hemoglobin(Hb),total cholesterol(TC),C-reactive protein(CRP),triglyceride(TG),calcium(Ca2+),and creatinine(CR)were measured;an automatic blood coagulation analyzer was used to measure serum thrombin time(TT),FIB,activated partial thromboplastin time(APTT),and plasma prothrombin time(PT);ELISA was used to measure the serum levels of endothelin-1(ET-1)and D-dimer(D-D);the thiobarbituric acid method was used to measure the level of malondialdehyde(MDA),and xanthine oxidase colorimetry was used to measure the level of superoxide dismutase(SOD).Coagulation function in CKD patients and risk factors for hypercoagulability were analyzed.Results The patients with stage 4/5CDK had a significantly higher serum level of FIB than those with stage 1/2CDK and the control group,a significantly higher serum level of D-D than those with stage 1CDK and the control group,and significantly longer TT and PT than the control group(F=12.466-14.620,P<0.05).Compared with the non-hypercoagulation group,the hypercoagulation group had significantly higher serum levels of MDA,TC,ET-1,CR,and CRP,a significantly higher incidence rate of cardiovascular diseases,and significantly lower levels of SOD,Alb,and Ca2+(t=10.189-14.083,χ2=10.694,P<0.05),while there were no significant differences between the two groups in mean age,number of patients who smoked,and levels of TG,PLT,and Hb(P>0.05).The logistic regression analysis showed that the serum levels of CRP and creatinine were independent risk factors for hypercoagulability(P<0.05).Conclusion Serum CRP and creatinine are independent risk factors for hypercoagulability in patients with CKD,and hypercoagulability is closely associated with oxidative stress and inflammation in vivo.
作者 林伟平 吴勇 LIN Weiping;WU Yong(Renal Medicine,Huizhou Central People’s Hospital,Huizhou 516000,China)
出处 《青岛大学学报(医学版)》 CAS 2019年第1期99-102,共4页 Journal of Qingdao University(Medical Sciences)
基金 惠州市科技计划项目(2016Y001)
关键词 肾疾病 炎症趋化因子类 血液凝固 氧化性应激 kidney diseases chemokines blood coagulation oxidative stress
  • 相关文献

参考文献21

二级参考文献175

  • 1丁德平,孟忠吉,柯昌征,李东,陈悦.乙肝肝硬化患者FIB-4指数与Child-Pugh分级相关性研究[J].湖北医药学院学报,2013,32(3):245-247. 被引量:3
  • 2《中国糖尿病防治指南》(试行本)(节选)[J].中国慢性病预防与控制,2004,12(6):283-285. 被引量:304
  • 3董如娇,张宏.糖尿病合并甲状腺异常的研究进展[J].国外医学(内分泌学分册),2005,25(6):388-390. 被引量:31
  • 4吴文蕾,李升,韩冰,钱海峰,张鹏.原发性纤维蛋白原溶解症致牙龈出血的临床分析(附病例报告)[J].口腔医学研究,2007,23(3):353-354. 被引量:8
  • 5Kidney Disease:Improving Global Outcomes(KDIGO)CKD-MBD fork Group.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J].Kidney Int Suppl,2009:S1-130.
  • 6National Kidney Foundation.K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease[J].Am J Kidney Dis,2003,42:S1-201.
  • 7Spasovski GB,Bervoets AR,Behets GJ,et al.Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis[J].Nephrol Dial Transplant,2003,18:1159-1166.
  • 8Klawansky S,Komaroff E,Cavanaugh PF,Jr.,et al.Relationship between age,renal function and bone mineral density in the US population[J].Osteoporos Int,2003,14:570-576.
  • 9Alem AM,Sherrard DJ,Gillen DL,et al.Increased risk of hip fracture among patients with end-stage renal disease[J].Kidney Int,2000,58:396-399.
  • 10Jamal SA,Bauer DC,Ensrud KE,et al.Alendronate treatment in women with normal to severely impaired renal function:an analysis of the fracture intervention trial[J].J Bone Miner Res,2007,22:503-508.

共引文献255

同被引文献66

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部